SHP-623

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSHP-623
Drug Alias NamerC1-INH-ShireSHP-623
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSerine protease hepsin inhibitors
TargetsSerine protease hepsin
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A